Advancing Cell & Gene Therapy Development & Manufacturing

Download BioCentriq's new eBook Setting the Stage for Successful Clinical Manufacturing of Cell and Gene Therapies.
Includes five chapters of actionable advice on how to ensure quality, improve patient access, and reduce the cost of manufacturing. Discover how to objectively assess your product’s GMP-readiness and save time and money along the way.
A Collaborative Cell Therapy CDMO
BioCentriq is a full-service, collaborative CDMO for cell and gene therapy, supporting all stages of process development and clinical manufacturing.
We employ expert scientists, engineers, analysts, and manufacturing specialists. Our established, phase appropriate quality systems and newly constructed facilities are designed to support the release of autologous and allogeneic drug products. In fact, BioCentriq has been manufacturing drug products for use in human trials since 2022.
In additional to custom development and manufacturing services, BioCentriq offers it's LEAPTM Advanced Therapy Platform which is designed to help early-stage biotech companies go from contract to clinic in as short as six months.
